Obalon Therapeutics Inc.

NASDAQ: OBLN · Real-Time Price · USD
3.05
-0.19 (-5.86%)
At close: Jun 16, 2021, 6:00 AM

Obalon Therapeutics Revenue

Obalon Therapeutics reported an annual revenue of $1.59M, reflecting a -51.6% growth. For the quarter ending June 30, 2021, Obalon Therapeutics generated $3.53K in revenue.
Revenue (ttm)
$1.59M
Revenue Growth
-51.6%
Price / Sales Ratio
7.34
Revenue / Employee
$794K
Employees
2
Market Cap
5.47M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.